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Abstract
Aorta-Atrial Fistulas (AAF) are a rare but complex pathological condition. These fistulas are
characterised by aberrant blood flow between the aorta and either atrium. In the present
manuscript, we present a comprehensive overview of the clinical characteristics, formation
and treatment of this condition.  A literature review was conducted using PubMed.  Aorta-
Atrial  Fistula  was  used  as  the  primary  search  term.  The  clinical  presentation  of  AAF
encompasses a wide range of signs and symptoms of heart failure including dyspnoea, chest
pain,  palpitations,  fatigue,  weakness  coughing  or  oedema.  Causes  of  fistulas  can  be
congential or acquired, whilst diagnosis is normally achieved via echocardiography or MRI.
Due to the low incidence of AAF, no clinical trials have been performed in AAF patients and
treatment  strategies  are  based  on  expert  opinion  and  consensus  amongst  the  treating
physicians. Uncorrected AAF may continue to impose a risk of progression to overt heart
failure. The repair of an AAF can either be surgical or percutaneous. AAF is a relatively rare
but very serious condition.  Clinicians should consider the possibility of AAF, when a new
continuous cardiac murmur occurs, especially in patients with a history of cardiac surgery or
with signs of heart failure. Closure of the AAF fistula tract is generally recommended. Further
studies are required to define optimal therapeutic strategies, but these are hindered by the
rarity of the occurrence of this disorder.
Keywords: Aorta Atrial Fistula; Treatment; Surgery
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Introduction
An Aorta-Atrial fistula (AAF) is a rare but complex pathological condition that can either be
congenital or acquired. Usually AAF is secondary to another pathological condition. An AAF
is characterised by the presence of the abnormal intra cardiac flow between the aorta and
the left or right atrium. The underlying disease needs to be understood thoroughly to enable
planning the optimal therapeutic strategy.  Here we present a comprehensive overview of the
clinical characteristics, subtypes of AAF, the role of the imaging modalities as well as different
therapeutic options to treat AAF. It is hoped that this overview will help clinicians in identifying
AAF as well as providing optimal treatment.
Clinical Presentation
AAF can affect patients from a broad age range, and has been described in patients ranging
from 5 days old to 85 years old (1,2). The clinical presentation of AAF encompasses a wide
range of signs and symptoms of heart failure including dyspnoea, chest pain, palpitations,
fatigue, weakness coughing or oedema. 
As the AAF redirects oxygen rich blood from the aorta through the fistula back into one of the
cardiac chambers, the mechanism of heart failure is thought to be due to a volume overload
and cardiac remodelling. Furthermore, and most likely related to the shunt volume, the AAF
can also result into distension of the atrial wall,  with or without subsequent occurrence of
atrial  fibrillation.  If  blood is redirected directly into the ventricles, extra volume can cause
increased ventricular strain and lead to cellular remodelling. Continuous right-sided volume
overload would eventually lead to an increase in pulmonary pressure, pulmonary oedema
and ultimately the development of right ventricular failure. Physical examination may reveal a
continuous murmur at the right upper sternal border. A murmur is, however, a non-specific
sign and is not indicative of the severity of the AAF. Despite this, when a new continuous
cardiac murmur is detected in patients with a history of cardiac surgery, an occurrence of
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AAF should be considered. This is especially true when other signs or symptoms of heart
failure  are  present.  Furthermore,  left-sided  volume  overload  can  cause  eccentric  left
ventricular hypertrophy and mitral annular dilation with secondary mitral insufficiency. This
will result in a worsening of heart failure symptoms, and may alter treatment options. 
Types of AAF
There are a number of manners in which AAF can evolve, and the anatomy of these different
configurations are shown in Figure 1.
Congenital AAF 
Reports of congenital AAF are less common compared to acquired AAF. Congenital AAF can
be  subdivided  into  two  major  sub-groups,  congenital  aorto-atrial  tunnels  and  coronary
cameral  fistulas.  Aorto-atrial  tunnels are congenital  anomalies originating above the sino-
tubular ridge, caused by an inherited weakness in the aortic wall, leading to the formation of
a tunnel into one of the atria (3). Coronary cameral fistulas occur when one of the coronary
arteries forms a shunt directly into the atria (3–5). Another very rare anomaly is the idiopathic
aortic root (sinus of Valsalva) atrial fistula which was recently described by Campisi et al (6).
Clinical presentation of congenital AAF can range from asymptomatic to severe heart failure.
Early  correction  of  these  anomalies  is  therefore  recommended  due  to  the  fact  that  the
symptoms  are  likely  to  worsen  over  time,  with  a  subsequent  higher  surgical  risk  when
patients become symptomatic(3,7–9).
Acquired AAF
Acquired  AAF  is  associated  with  a  wide  range  of  conditions  as  shown  in  Table  1.
Endocarditis  is  one of  the most  important  contributory  causes of  AAF.  The inflammatory
processes involved in this disease, together with bacterial destruction of tissue, can weaken
the integrity of the aortic and atrial walls and hence increase vulnerability to fistula formation.
The incidence of AAF in the setting of endocarditis ranges from 1.6% in patients with native
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valves up to 5.8% in patients with a prosthetic  valve  (10).  Often a paravalvular  abscess
coincides with an endocarditis infected aortic root. This can be detected on transesophageal
echocardiography, in the mid-esophageal long axis view (Figure 2). These abscesses can
destroy  cardiac  tissue  and  protrude  into  a  cardiac  cavity.  In  the  majority  of  infective
endocarditis cases, the fistulous communication is between the aorta and the adjacent left
atrium(11,12).
Certain common cardiac surgical  procedures can also be associated with AAF formation
without endocarditis (Table 2).  In cases where infection is not present, fistulas are generally
more common between the aorta and the right atrium than aorto-left atrial fistulas. Fistula
formation between the left atrium and aorta is very rare due to the anatomical position of
these structures. The occurrence of AAF in aortic surgery is much more common compared
to coronary artery bypass grafting (CABG) surgery. It is thought that suture-related causes,
as well as the location of the suture area, are detrimental factors related to the risk of AAF
formation. In patients without a history of cardiac surgery or infection, ruptured sinus valsalva
aneurysm, aortic dissections or aneurysms are the major cause of AAF formation. 
Special consideration should also go to patients who have undergone percutaneous closure
of atrial septal defects using an occluding device. Erosion through the atrial wall due to the
oversizing of the occlude device or a deficient aortic rim can result in fistula formation. It has
previously  been assumed that  motion of  the  cardiac wall  in  conjunction  with  the closing
tension of  the device may cause the edge of  the disk to erode into the aortic wall  (13).
Therefore, long-term follow-up of these patients is essential, especially when large devices
have been implanted. It has also been recommended to avoid the use of closure devices in
patients with an aortic rims of less than 5 mm (14).
Systemic diseases associated with vasculitis such as Behcet’s disease or Kawasaki have a
higher overall incidence of developing vascular fistula(15,16). For example, we identified two
cases of AAF in patients with vasculitis,  one patient  with Behcet’s disease with no other
cardiac anomalies and finally a patient with giant cell arteritis, who had undergone a repair of
an aortic dissection(17,18). 
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Although connective tissue diseases (e.g Marfan) have a higher  incidence of  developing
vascular abnormalities such as aortic aneurysms, to our knowledge, no reports on AAF are
currently available in this patient category. Other incidental causes of acquired AAF reported
in literature include chest trauma and placements of extra-cardiac stents with subsequent
migration of these stents(19–21).
Imaging techniques to diagnose AAF
Echocardiography
Both transesophageal echocardiography (TEE) and trans-thoracic echocardiography (TTE)
can be used to evaluate AAF. Colour Doppler TEE often provides superior image quality in
cases where fistulas occur from the posterior aspect of the aorta due to the more optimal
alignment of the probe.  TTE, on the other hand, renders a better orientation of the atria
compared to TEE. 3D-TEE might become the future method of choice for the assessment of
AAF because 3D imaging allows spatial orientation and high anatomic definition of adjacent
structures(11,22,23).  
A major  benefit  of  echocardiography  is  the  possibility  to  examine cardiac  defects  in  the
operating  room  at  all  stages  of  surgery  (before,  during  and  after).  Possible  drawbacks
include the requirement of high-frequency transducers with high spatial resolution in certain
type of patients, limitations in evaluation of vascular structures positioned outside the heart
and sometimes TEE probe insertion is contra-indicated.
Cardiac Magnetic Resonance Imaging and Cardiac Catheterization
Cardiac Magnetic Resonance Imaging (CMR) has proven to be superior in the quantification
of cardiac shunt fraction and flow measurements when compared to echocardiography and
computed tomography (CT) alone(24). Sensitivity of CMR to detect aortic vascular anomalies
is comparable to angiocardiography. However, with regard to pulmonary artery flow, CMR is
the only available technique that allows quantitative flow measurements and is considered
the gold standard for assessment of pulmonary vein anomalies(24,25). In cases of  intra-
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cardiac  shunts,  CMR  can  be  used  for  anatomical  detection  and  calculation  of  shunt
fraction(26,27). Drawbacks of CMR are its inability to be used intraoperatively and the use of
gadolinium-based dye as a contrast medium, which has been associated with nephrogenic
systemic fibrosis.
Cardiac catheterization can also be used to accurately assess shunt quantification, but flow
measurements  are  less  accurate  compared  to  CMR(24).  The  drawback  of  cardiac
catheterization  is  mainly  its  invasive  nature,  which  has  its  inherent  risks  and  potential
problems.
Therapy of AAF
Once an AAF is diagnosed, the underlying disease needs to be understood thoroughly to
plan the optimal therapeutic strategy.  Due to the low incidence of AAF, no clinical trials have
been performed in these patients and treatment strategies are based on expert opinion and
consensus amongst the treating physicians. Correction of an AAF is strongly recommended
when the AAF is not trivial. Uncorrected AAF may continue to impose a risk of progression to
overt heart failure. The repair of an AAF can either be surgical or percutaneous. Surgical
closure  of  an  AAF  is  usually  based  on  patches  or  ligation  of  the  fistula  tract  and
percutaneous closure can be achieved by using an occluder device,  coil  embolization or
covered stents.  In the case of percutaneous closure with an occluder device, an  Amplatz
Ductal  Occluder  device  is  most  commonly  used  (28).   In  all  patients  who  undergo
percutaneous  closure  with  an  Amplatzer  device  follow-up  through  postop  imaging  is
necessary to detect if there is a residual fistula or pseudoaneurysm present (29). Given that
the majority of information regarding AAF is from case reports, it  is difficult  to accurately
gauge the treatments success rates or mortality rates. However, a recent review of these
case reports from our own group indicated that the overall treatment success rate for both
surgical and percutaneous closure is above 80%. The mortality rate for both surgical and
percutaneous closure using the same data set was around 7% (30).
Small asymptomatic aorto-atrial fistulas can sometimes be managed pharmacologically, by 
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reduction of cardiac afterload and the use of diuretics. Conservative management should 
involve close monitoring of the patient and if clinical conditions deteriorates, active closure of 
the fistula should be reconsidered. Clinicians should always keep in mind that even 
asymptomatic and small AAF have a tendency to worsen over time, with subsequent higher 
surgical risk when patients become symptomatic. 
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Conclusion
AAF is a relatively rare but very serious condition. Clinicians should consider the possibility of
AAF, when a new continuous cardiac murmur occurs, especially in patients with a history of
cardiac surgery or with signs of heart failure. Pre-operative localisation and quantification of
intra-cardiac shunts can best be studied using CMR, whereas echocardiography is ideal to
provide perioperative assessment and guidance for the surgeon. In the absence of clinical
trials, clinical approach in treating AAF is based on expert opinion and consensus. Closure of
the AAF fistula tract is generally recommended, even if the fistula is asymptomatic, based on
observations  that  AAF  have  a  tendency  to  worsen  over  time.  Further  studies  would  be
required to define optimal therapeutic strategies, but these are hindered by the rarity of the
occurrence of this disorder.
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Figure Legends
Figure 1: Anatomy of Aorto-Atrial Fistulas
Figure 2: Aortic root abcess as seen on transesophageal echocardiography, panel A; mid-
esophageal aortic short axis view and panel B; mid-esophageal aortic long-axis view, show 
multiple abcess chambers (arrows) in the aortic root.
Table Legends
Table 1: Conditions associated with acquired AAF
Table 2: Cardiac surgical procedures associated with AAF formation:
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Table 1:
Conditions associated with acquired AAF:
- Endocarditis
- Previous cardiac surgery
- Aorta dissection/aneurysms
- Ruptured Sinus of Valsalva Aneurysm
- Iatrogenic (suture or perforation associated)
- Vasculitis (Behcet’s disease, giant cell 
arthritis)
- Trauma
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Table 2: 
Cardiac surgical procedures associated with AAF 
formation:
- Aorta (root) surgery
- Valve surgery (especially of the aortic valve)
- Coronary artery bypass graft surgery
- Percutaneous closure of atrial septal defects (ASD)
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